NYSE: NGVTIngevity Corp Stock Ownership - Who owns Ingevity?
Insider buying vs selling
Have Ingevity Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Phillip John Platt | SVP Finance CAO | 2025-08-11 | 1,444 | $52.20 | $75.38kSell |
| Ryan C. Fisher | SVP Gen. Counsel Secretary | 2025-07-07 | 169 | $45.34 | $7.66kSell |
| J. Kevin Willis | Director | 2025-07-01 | 620 | $44.40 | $27.53kBuy |
| Francis David Segal | Director | 2025-07-01 | 507 | $44.40 | $22.51kBuy |
| J. Kevin Willis | Director | 2025-05-01 | 151 | $33.28 | $5.03kBuy |
| Francis David Segal | Director | 2025-05-01 | 677 | $33.28 | $22.53kBuy |
| J. Kevin Willis | Director | 2025-04-01 | 580 | $38.85 | $22.53kBuy |
| Ryan C. Fisher | SVP Gen. Counsel Secretary | 2025-03-25 | 310 | $43.07 | $13.35kSell |
| Mary Dean Hall | EVP Chief Financial Officer | 2025-02-28 | 562 | $47.66 | $26.78kSell |
| Steven Paul Hulme | SVP and Pres APT | 2025-02-28 | 152 | $47.66 | $7.24kSell |
NGVT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NGVT insiders and whales buy or sell their stock.
NGVT Shareholders
What type of owners hold Ingevity Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.42% | 5,623,855 | $327.03M | Institution |
| Vanguard Group Inc | 11.23% | 4,095,493 | $238.15M | Institution |
| Wellington Management Group LLP | 5.98% | 2,182,170 | $126.89M | Institution |
| American Century Companies Inc | 4.68% | 1,707,273 | $99.28M | Institution |
| State Street Corp | 4.11% | 1,498,094 | $87.11M | Institution |
| Segall Bryant Hamill LLC | 3.52% | 1,283,210 | $74.62M | Institution |
| Millennium Management LLC | 3.22% | 1,173,962 | $68.27M | Institution |
| Thrivent Financial For Lutherans | 3.11% | 1,135,400 | $66.02M | Institution |
| Royce Associates LP | 3.01% | 1,099,359 | $63.93M | Institution |
| Brown Advisory Inc | 2.55% | 928,835 | $54.01M | Institution |
NGVT vs Specialty Chemical Stocks
Ingevity Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.